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Early B blasts acquire a capacity for Ig class switch
recombination that is lost as they become plasmablasts
Jennifer L. Marshall, Yang Zhang, Lalit Pallan, Mei-Chi Hsu,
Mahmood Khan, Adam F. Cunningham, Ian C. M. MacLennan
and Kai-Michael Toellner
MRC Centre for Immune Regulation, the School of Immunity and Infection, University of
Birmingham, Birmingham, UK
Rapid production of neutralizing antibody can be critical for limiting the spread of infec-
tion. Such early antibody results when B-cell blasts mature directly to plasmablasts
without forming germinal centers. These extrafollicular responses can involve Ig class
switch recombination (CSR), producing antibody that can readily disseminate through
infected tissues. The present study identifies the differentiation stage where CSR occurs in
an extrafollicular response induced by 4-hydroxy-3-nitrophenyl acetyl (NP) conjugated to
Ficoll (NP-Ficoll). To do this, we took advantage of the antigen dose dependency
of CSR in this response. Thus, while both 30 and 1lg NP-Ficoll induce plasmablasts, only
the higher antigen dose induces CSR. Activation-induce cytidine deaminase (AID) is
critical for CSR and in keeping with this a proportion of NP-specific B-cell blasts induced by
30 lg NP-Ficoll express AID. None of the B blasts responding to the non-CSR-inducing 1 lg
dose of NP-Ficoll express AID. We confirmed that CSR occurs in B blasts by demonstrating
the presence of rearranged heavy-chain transcripts in B blasts in the 30 lg response.
CSR in this extrafollicular response is confined to B blasts, because NP-specific plasma-
blasts, identified by expressing CD138 and Blimp-1, no longer express AID and cannot
undergo CSR.
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Introduction
The rapid induction of neutralizing antibody can be a critical
factor in limiting the spread of the extracellular infection [1–3].
This is achieved by direct antigen-driven differentiation of B cells
into B blasts and then plasmablasts and plasma cells without
going through an affinity maturation stage in germinal centers
[4–6]. For this reason, the rapid route to antibody production is
commonly referred to as the extrafollicular response, and these
lead to the production of nonswitched and switched antibodies.
While the induction of class switch recombination (CSR) seems to
happen at the follicle – T-zone interphase [6], the earliest class-
switched B cells have been observed in follicles [7]. The object of
the present study is to identify differentiation stages during
extrafollicular antibody responses when CSR occurs, and whether
these relate to germinal center (GC) or plasmablast differentia-
tion. To do this, we have studied B cells responding in vivo to the
thymus-independent type 2 (TI-2) antigen 4-hydroxy-3-nitro-
phenyl acetyl conjugated to Ficoll (NP-Ficoll). The characteriza-
tion of cells at the single-cell level early in the response has been
facilitated by the use of F1 hybrids of QM and C57BL/6 mice
(QMxB6 mice). These hybrids have one copy of a targeted
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insertion of a rearranged NP-specific Ig heavy chain [8]. The 5%
of B cells that have a productive lambda light chain rearrange-
ment in these mice are specific for NP [9].
NP-Ficoll induces an impressive extrafollicular antibody
response in QMxB6 mice. In addition, at high antigen doses, it
can induce GCs [10]. These GCs, however, are abortive, for the
GC B cells enter apoptosis at the stage when their continued
survival depends on antigen-specific selection by T cells. In this
study, we use a combination of flow cytometry with single-cell
sorting and real-time RT-PCR to identify responding B blasts from
plasmablasts and GC-founding cells. Differentiation of B blasts
toward plasmablasts or GC B cells is tightly regulated by a
network of transcription factors. We used the expression of three
of these to distinguish B blasts, plasmablasts, and GC-founding
cells. The main transcription factor associated with confirmed
differentiation toward the plasmablast phenotype is Blimp-1,
encoded by the gene Prdm1 [11]. Blimp-1 in combination with
surface expression of CD138 is used to identify plasmablasts. The
master regulator of GC B-cell commitment is Bcl6. Bcl6 and
Blimp-1 mutually repress each other [12–14]. The coexpression
of activation-induced cytidine deaminase (AID) with Bcl6 is used
to identify GC-founding cells. AID is essential for CSR and is
required for Ig V-region hypermutation in GCs [15]. It is well
documented that CSR occurs in GCs [16]. The question addressed
below is whether AID is expressed in B blasts or plasmablasts or
both of these cell types as they develop along the extrafollicular
pathway, and whether this expression is associated with CSR.
Results and discussion
CSR occurs in B blasts rather than plasmablasts
responding to NP-Ficoll
To identify where and when CSR occurs in the response to NP-
Ficoll, it is necessary to summarize the pattern of migration and
differentiation of NP-specific B cells in responses to NP-Ficoll. As
in WT mice [17] NP-specific cells from QMxB6 mice move from
the marginal zone and follicles to the T zone within 8 h of
immunization with 30 mg NP-Ficoll (Fig. 1A, top two panels). The
responding cells enter cell cycle by 24 h after immunization (data
not shown). By 48 h postimmunization proliferation has
increased the number of NP-specific cells (Fig. 1B, top) and B
blasts are spread throughout the white pulp (Fig. 1A, lower left).
The white arrowheads in this photomicrograph identify the first
CD1381 plasmablasts, which have appeared where the red
pulp abuts to the T zone. This is reflected by an increase in
NP1CD1381 cells seen by flow cytometry (Fig. 1B, bottom). By
72 h large accumulations of CD1381 plasmablasts fill the red
pulp, although there are still many B blasts in the white pulp
(Fig. 1A, center bottom panel). Clusters of Bcl61 NP-specific
GC-founding B blasts first appear in the center of follicles
at 72 h, whereas Bcl6 expression is not seen prior to immuniza-
tion or in nonresponding naı¨ve B cells (Fig. 1A, bottom right).
Quantitative immunohistology shows that by 72 h a significant
proportion of the plasmablasts have switched to IgG3 (Fig. 1D,
left panel).
To determine whether CSR induced by 30 mg NP-Ficoll takes
place in the B blasts, or plasmablasts, or both of these cell types,
responding B cells were sorted by flow cytometry (Fig. 1C). NP-
specific B cells were identified as B2201 cells that bind NP-
conjugated to phycoerythrin (PE). At 24 h after immunization,
NP-PE binding by NP-specific cells is markedly reduced, probably
due to competition for BCR ligation with the immunogen and/or
BCR internalization. To detect NP-specific cells at this time point,
mice were immunized with NP-FITC-Ficoll and FITC-positive cells
were sorted (cells shown in red in Fig. 1B inset). The expression
of CD138 (blue gate) was used to distinguish plasmablasts from
B blasts (red gate, which includes GC founding cells).
Bulk sorts of NP-specific cells at 24 h intervals post-
immunization were analyzed to identify the appearance of heavy-
chain transcripts containing Im apposed to IgG3 heavy-chain
genes (Fig. 1D, center panel). These rearranged heavy-chain
transcripts can only be expressed in cells that have completed
CSR to IgG3 [18], and are a good indicator of the frequency of
class-switched cells, as the Im exon is constitutively active [19].
There is a significant accumulation of the Im-Cg3 transcripts in the
B-blast population sorted at 48 h. Both the plasmablast and the
B-blast populations have higher levels of these transcripts at 72 h
(Fig. 1D, center).
These observations indicate that CSR does occur in B blasts in
this response but not if this process continues in plasmablasts. To
probe this, the same bulk sorts were tested for the expression of
Aicda transcripts. This shows that some cells in the B-blast frac-
tions at 48 and 72 h express AID, whereas the plasmablast frac-
tion does not (Fig. 1D, right panel). At this time, UNG mRNA has
also been induced (Supporting Information Fig. 1), but blasts still
express Pax5 mRNA, the main transcription factor associated
with B-cell phenotype, and do not express XBP1 mRNA, which
drives Ig secretion in plasma cells (Supporting Information Fig. 1)
These results show that by the time cells responding to NP-Ficoll
express CD138 they have lost the capacity to initiate further CSR.
At 48 h after immunization, B blasts are found in all compart-
ments of the white pulp. Class-switched B blasts, as opposed to
GC blasts, have also been identified in follicles and T zones at the
early stages of T-dependent responses [7, 20]. The precise
features of the microenvironments within the white pulp where
CSR occurs in B blasts remain to be determined.
Single-cell analysis confirms that a proportion of
extrafollicular B blasts express AID, while
plasmablasts do not
To determine the proportion of B blasts that express AID
transcripts and whether these have transcriptional regulation
similar to emerging extrafollicular plasmablasts or GC founding
cells, multiplex real-time RT-PCR was carried out on single cells.
Figure 2A–D show representative individual experiments in
which single NP-specific cells were sorted into the wells of
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Figure 1. The emergence of plasmablasts, GC-founding cells, and Ig class switching. QMxB6 mice were immunized i.p. with 30mg NP-Ficoll. (A) The
location and differentiation of NP-specific B cells in the spleen are shown by immunohistology. Before immunization (top left, 0 h), NP-binding
B cells (blue) are located mainly in the marginal zone (MZ) and follicles (F). Follicles are identified by the presence of IgD1 B cells (brown). By 8 h (top
right), the NP-specific B cells are located in the outer T zone (T). At 48 h (bottom left) NP-binding cells fill the white pulp; arrowheads indicate
darker-staining plasmablasts at the red pulp (RP)-T zone junction. At 72 h CD1381 red pulp plasmablasts (PB) stained for CD138 (blue) crowd the red
pulp (bottom center) and clusters of Bcl61 germinal center-founding cells fill the follicle centers (bottom right). (B) Total numbers of NP-binding
cells and CD1381 NP-binding plasmablasts and plasma cells, determined by flow cytometry. Boxes represent median and lower and upper quartile,
whiskers represent minimum and maximum values. (C) Flow cytometric sorting of NP-binding B cells responding to NP-Ficoll. In all, 5% of
C57B6xQM mouse B cells are NP-specific preimmunization (left); 24 h after immunization B cells bind NP-PE less efficiently (middle left), and are
detected via NP-FITC-Ficoll staining used as immunogen (red, inset); 72 h after immunization NP-binding B cells are divided into two fractions
(right): CD138– B2201 and CD1381. (A–C) In total, 4–12 animals were used per time point in three independent experiments. (D) Increase in the
number of IgG3 expressing cells, assessed by immunohistochemistry (left). The relative amounts of recombined Im-Cg3 heavy-chain transcripts
(center) or Aicda mRNA (right) assessed by real-time RT-PCR in NP-binding cells sorted using the gates shown in (B). The colors of the diamonds
correspond to the colors of the gates in (C). Each diamond represents data from sorted cells of one mouse from three independent experiments.
Statistics indicate Mann–Whitney U-test results.
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384-well plates on the left hand side. They were then assessed for
the expression of mRNA for AID with Bcl6, or AID with Blimp-1.
To exclude empty wells, each well was assessed for the
constitutively expressed b2-microglobulin – as described in the
Materials and methods. Graphs on the right-hand side show a
summary of the single-cell RT-PCR results from all the individual
experiments.
Neither AID nor Blimp-1 was expressed in NP-PE-binding
B2201 cells before immunization (Fig. 2B and C, right side). By
contrast, some 40% of these cells express Bcl6 message (Fig. 2A).
Despite the presence of Bcl6 mRNA, naı¨ve B cells express little or
no Bcl6 protein at levels detectable by immunoenzymatic staining
(Fig. 1A and [21]). Bcl6 mRNA is progressively lost following
immunization (Fig. 2A), and is only re-expressed in germinal
center-founding cells 72 h after immunization (Fig. 2D). The
appearance of cells coexpressing Bcl6 and AID mRNA at high
levels (median 10 higher) coincides with the appearance of
clusters of NP-specific cells in follicle centers that express Bcl6
protein, as shown by immunohistology (Fig. 1A, bottom right).
Figure 2B confirms that AID is induced in B blasts. AID mRNA is
first found in B blasts 48 h post-NP-Ficoll. At this stage, when no
AID1/Bcl61 coexpressing GC-founding cells are present (Fig. 2D,
right), AID mRNA is expressed in the absence of Bcl6 mRNA in
around 10% of B blasts. Cells with this phenotype are still present at
72 h (Fig. 2B, right). In striking contrast, CD1381 NP-binding cells
do not express AID. This even applies to the small number of early
plasmablasts that are present at 48 h after immunization. At this
stage, a median of 80% of the CD1381 cells express Blimp-1 mRNA,
whereas 495% of these cells express Blimp-1 at 72 h. The presence
of a significant minority of CD1381 cells that do not express Blimp-
1 raises the question whether this regulator of plasmablast differ-
entiation is the sole repressor of AID. Out of 683 cells studied in
total, only 3 showed coexpression of Bcl6 and Blimp-1.
The antigen dose dependency of AID induction and
switching induced by NP-Ficoll
We have previously reported that higher doses of NP-Ficoll are
required to induce the NP-specific B cells of QM mice to produce
GCs than are needed to induce the production of extrafollicular
plasmablasts [10]. Serendipitously, on reviewing this earlier
study, we identified an effect of antigen dose on CSR. While 1 mg
of NP-Ficoll is sufficient to induce a significant number of NP-
specific B blasts to mature into plasmablasts (Fig. 3A, B and
Supporting Information Fig. 2), it does not induce CSR (Fig. 3D).
The expression of the proliferation marker Ki-67 distinguishes the
plasmablasts induced by 1 mg NP-Ficoll from the background
plasma cells seen in QMxB6 mice, which typically are not
proliferating (Fig. 3A and C). NP-binding plasmablasts and B
blasts were sorted from mice 48 h after immunizing with 1 or
30 mg of NP-Ficoll and the expression of AID message was again
assessed by single-cell real-time RT-PCR (Fig. 3E). AID was
expressed by a proportion of the B blasts from mice immunized
with 30 mg of NP-Ficoll, but was not expressed in any cells from
mice immunized with 1mg of NP-Ficoll, confirming that early
expression of AID is related to CSR in extrafollicular B
differentiation.
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Figure 2. Transcriptional differentiation of B blasts, plasmablasts, and
GC-founding cells. Single cells from the spleens of QMxB6 mice
immunized with 30 mg NP-Ficoll were FACS-sorted into 384-well plates
using the gates shown in Fig. 1C. The mRNA levels for AID and Bcl6, or
AID and Blimp-1 in each cell were determined by real-time RT-PCR.
(A) Left: Bcl6 and AID mRNA expression in nonimmune NP-binding
B cells. Each diamond corresponds to one cell. Data are from one
representative animal. Right: the percentage of cells that are Bcl61
AID in individual mice (each diamond corresponds to one mouse,
derived from three independent experiments. Color of diamond
indicates population as in Fig. 1C and D. (B) Left: Bcl6 and AID mRNA
expression at 48 h in NP-binding B cells. Right: the percentage of cells
from different sorted subsets that are AID1 Bcl6. (C) Left: AID and
Blimp-1 mRNA expression at 72 h in individual NP-binding CD1381
cells. Right: percentage of cells in each subset expressing Blimp-1 and
no AID mRNA. (D) Left: expression of Bcl6 and AID mRNA in
NP-binding B2201 CD138 cells. Right: The percentage of cells from
the sorted cell subsets that are AID1 and Bcl61. Numbers on the
horizontal and vertical axes in the single-cell PCR plots (left graphs)
represent the PCR cycle when signal above threshold was reached (Ct),
which corresponds to a log2 scale of mRNA quantity per cell.
Percentages indicate the proportion of cells in each quadrant.
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Concluding remarks
Although CSR is associated with B-cell proliferation and
differentiation in germinal centers [22, 23], CSR is also
induced during extrafollicular plasmablast differentiation. During
the initial response to T-dependent antigens [6], and in
responses to thymus-independent type 2 antigens, it is the only
pathway of productive B-cell differentiation and CSR [17].
We show here that AID induced by NP-Ficoll is expressed at
lower levels than in GC blasts and is not coexpressed with
Bcl6. Germinal center independent class switching may
represent an ancient pathway of AID induction that developed
before proper germinal centers evolved, as is seen in lower
vertebrates that develop plasma cells and undergo CSR in the
absence of germinal centers [24]. CSR occurring before affinity
maturation happens may seem counterproductive, as a switch
from IgM to IgG leads to a loss of avidity of the resulting
antibody. On the other hand, infections often induce efficient
extrafollicular plasmablast differentiation, whereas germinal
center development is delayed. The gain of additional effector
function from switched immunoglobulin may be critical
in providing early protective immunity from life-threatening
infections [25].
Materials and methods
Animals and immunizations
QM mice [8] (backcrossed to C57BL/6J for 410 generations)
were bred under specific pathogen-free conditions in the
Biomedical Services Unit, University of Birmingham. QMxB6
mice were generated by crossing mice homozygous for the NP-
specific (VH17.2.25-DSP2.3-JH4) Ig heavy-chain segment of QM
mice and k light chain deficient with C57BL/6 mice to generate
mice with one copy of the NP-specific QM IgH and k light-chain
genes. Animal experiments were licensed by the British Home
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Figure 3. The antigen dose dependency of AID-induction and switching induced by NP-Ficoll. QMxB6 mice were immunized i.p. with either 30 or
1 mg of NP-Ficoll. (A) The induction of NP-specific plasmablasts (blue) in the red pulp of mice by 1mg NP-Ficoll either before immunization (left), or
96 h after immunization (right) is shown. Red boxes show magnifications of the same clusters of plasma cells or plasmablasts in serial sections
stained for the proliferation-associated marker – Ki-76 (brown) and NP-binding (blue). (B) Flow cytometric quantification of numbers of CD1381
NP-binding cells in the spleen of mice immunized 72 h after immunization with 1 or 30mg NP-Ficoll. (C) The proportion of NP-specific plasmablasts
that are Ki-671 in spleen sections 96 h after immunization with 1 mg NP-Ficoll, as shown in (A). Data are mean1SD of n5 4 mice. (D) Assessment of
the numbers of plasmablasts switched to IgG3 in sections of spleen taken 96 h after immunizing with 1 or 30mg. (E) The proportion of NP-binding
cells from the spleens of QMxB6 mice 48 h after immunization with 1 or 30 mg NP-Ficoll that express mRNA for Blimp-1, or Bcl6, or AID without Bcl6
assessed by single-cell real-time RT-PCR. (A, B, D, and E) Data are representative of two independent experiments.
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Office according to the Animals Scientific Procedures Act 1986
and approved by the University of Birmingham Biomedical
Ethical Review Subcommittee.
Immunizations
Mice were immunized i.p. with either 30 or 1mg NP40-Ficoll or,
when 24 h time points were taken, 30 mg NP-fluorescein-Ficoll
(Biosearch Technologies, Novato, CA, USA).
Antigen-specific B-cell staining and isolation
Location of antigen-specific idiotype-positive B cells in frozen
spleen sections was detected by immunohistology as described
previously [6]. Briefly, acetone-fixed frozen spleen sections
(6 mm) were stained using rat anti-mouse IgM, IgD, or CD138
(BD Biosciences, Oxford, UK), rat anti-mouse IgG3 (Serotec,
Oxford, UK), sheep anti-mouse IgD (The Binding site, Birming-
ham, UK), rabbit anti-mouse Bcl6 1/30 (Santa Cruz Biotechnol-
ogy, CA, USA), or NP conjugated to rabbit Ig. Secondary
antibodies conjugated to biotin or horseradish peroxidase were
applied. The biotinylated secondary antibodies were detected
using biotin-conjugated StreptABComplex-alkaline phosphatase
complex (Dako, Ely, UK).
Immunostaining of single-cell splenocyte suspensions following
immunization with NP-Ficoll used B220-FITC (eBioscience),
CD138-APC, or CD138-biotin, followed by streptavidin-PerCpCy5.5
or streptavidin-APC (BD Biosciences), and NP-PE (Biosearch Tech-
nologies). Antigen-specific B cells 24 h after immunization with NP-
FITC-Ficoll were identified by their FITC uptake and NP-PE plus
B220-APC staining. Cell sorting was carried out on a MoFlo cell
sorter (DakoCytomation). Sorted populations were checked for
purity and frozen at 801C immediately after sorting.
Real-time RT-PCR
RNA was extracted from frozen cell pellets. Im-Cg3 transcript was
detected by real-time RT-PCR with primers TCTGGACCTCTCC-
GAAACCA and ACCGAGGATCCAGATGTGTCA together with the
FAM-BHQ-labeled probe CTGTCTATCCCTTGGTCCCTGGCTGC
(Eurogentec, Southampton, UK) in multiplex with b-actin-specific
primers as described previously [25]. AID, Pax5, UNG, and XBP1
were detected using TaqMan gene expression assays
Mm00507774_m1, Mm00435501_m1, Mm00449156_m1, and
Mm00457359_m1 (Applied Biosystems, Foster City, CA, USA).
Single-cell RT-PCR
Single cells were sorted into wells, containing 1mL nuclease-free
water, of 384-well PCR plates using an automatic cell cloning unit
of a MoFlo cell sorter. Serial dilutions of 0–32 cells per well served
as positive and one row without cells as negative controls. After
sorting, plates were stored and frozen at 801C. Triplex real-time
RT-PCR used primers in limiting concentrations with QuantiTect
Multiplex RT-PCR buffer (Qiagen, Crawley, UK) in a final volume
of 6mL. The following primers and probes were used:
b2-microglobulin (CTGCAGAGTTAAGCATGCCAGTAT 100 nM,
ATCACATGTCTCGATCCCAGTAGA 100 nM, NED-CGAGCCCAA-
GACC-MGB, Applied Biosystems). Blimp-1 (CAAGAATGCCAACAG-
GAAGTATTTT 80 nM, CCATCAATGAAGTGGTGGAACTC 100 nM,
FAM-TCTCTGGAATAGATCCGCCA-MGB, Applied Biosystems),
Aicda (GTCCGGCTAACCAGACAACTTC 60 nM, GCTTTCAAAATCC-
CAACATACGA 100 nM, TET-TGCATCTCGCAAGTCATCGACTT
CGT-BHQ1, Eurogentec). Bcl6 was detected with primers (CAGA
CGCACAGTGACAAACCA, 60 nM, ACTGCGCTCCACAAATGTTACA
300 nM) and probe FAM-CAGCCACAAGACTGTCCACACGGGT-
BHQ1 (Eurogentec) in multiplex with Aicda, or CalFluor560-
CAGCCACAAGACTGTCCACACGGGT-BHQ1 (BioSearch Techno-
logies) in multiplex with Blimp-1. Reactions were run for 40 cycles
in a 7900 Real-Time PCR System (Applied Biosystems). Data from
wells that were positive for b2-microglobulin mRNA were plotted
as cycle number at which target gene was higher than threshold
(Ct) in reverse order, which corresponds to mRNA quantity per cell
on a log2 scale. Preliminary experiments showed that this setup
produced semi-quantitative results with good negative correlation
between Ct and log2 of the amount of template mRNA (Supporting
Information Fig. 3).
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